Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.01.010Source: DataRank Database

Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report is a research paper published in Transplantation and Cellular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: hybridTopics (34)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Joseph Caveney,Bin Yao,Teresa Lopes Ramos ORCID,Jan Bögeholz ORCID,Kartoosh Heydari

Live enrichment

PubMed:35042013 PMC:PMC8760704

National Heart, Lung, and Blood Institute

Grant: OT2HL152830

National Cancer Institute

Grant: P01CA049605

California Institute for Regenerative Medicine

Grant: DR2A-05365

National Institutes of Health

Grant: 1OT2HL152830-01

Novel Conditioning for Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: Use of an Antibody that Targets CD117

National Institutes of Health

Grant: 5P01CA049605-08

MARROW GRAFTING FOR THE LYMPHOMAS

H. L. Snyder Medical Foundation

National Institutes of Health

Astellas Pharma US

Servier

hybridLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.jtct.2022.01.010

publisherhttps://api.elsevier.com/content/article/PII:S2666636722000306?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636722000306?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8760704

repositoryhttps://escholarship.org/uc/item/1ks658j1

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansNeoplasm Recurrence, LocalCryopreservationHematopoietic Stem Cell TransplantationRetrospective StudiesPandemicsCOVID-19

Keywords

Reduced-intensity ConditioningEngraftment FailureGraft CompositionCryopreserved Allografts2747 Transplantation2720 Hematology610610 Medicine & health2700 General Medicine1307 Cell BiologyFull Length Article617HumansPandemicsRetrospective StudiesCryopreservationHematopoietic Stem Cell TransplantationCOVID-19Neoplasm RecurrenceLocal1313 Molecular Medicine10032 Clinic for Oncology and Hematology2723 Immunology and AllergyNeoplasm Recurrence, Local

Sustainable Development Goals

SDG 3: 3. Good health